Why Novavax and Johnson & Johnson Stocks Slipped Today
As a company, if the need for your latest and highest-profile product is declining rapidly, some investors are likely to bail.
That dynamic was very much in force with Novavax (NASDAQ: NVAX) stock on Monday, and to a lesser extent with its healthcare industry peer Johnson & Johnson (NYSE: JNJ) following President Joe Biden's remarks on the coronavirus pandemic during a TV interview. The former's share price cratered by almost 7%, while the latter's slipped by nearly 1%.
The president was interviewed on the show 60 Minutes on Sunday. Reporter Scott Pelley asked him directly if the pandemic was at an end, and Biden responded in the affirmative.
Source Fool.com
